Institutional investors purchased a net $15.5 thousand shares of ROSG during the quarter ended June 2016 and now own 6.65% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MORGAN STANLEY & CO. LLC Bought 44.0 Thousand shares of Rosetta Genomics Ltd
TWO SIGMA SECURITIES LLC Bought 23.1 Thousand shares of Rosetta Genomics Ltd
UBS FINANCIAL SERVICES, INC. Bought 1.5 Thousand shares of Rosetta Genomics Ltd